106 related articles for article (PubMed ID: 24341412)
1. Impaired immune defense in hemodialysis patients: role of α-defensins?
Grupp C; Troche-Polzien I; Noeding C; Mueller CA; Mueller GA
Hemodial Int; 2014 Apr; 18(2):443-9. PubMed ID: 24341412
[TBL] [Abstract][Full Text] [Related]
2. Alpha-defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection.
Aceti A; Mangoni ML; Pasquazzi C; Fiocco D; Marangi M; Miele R; Zechini B; Borro M; Versace I; Simmaco M
J Viral Hepat; 2006 Dec; 13(12):821-7. PubMed ID: 17109681
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
[TBL] [Abstract][Full Text] [Related]
4. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
5. Detection of colorectal disease by stool defensin assay: an exploratory study.
Zou H; Harrington JJ; Sugumar A; Klatt KK; Smyrk TC; Ahlquist DA
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):865-8. PubMed ID: 17531545
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction.
Friedrich B; Alexander D; Janessa A; Häring HU; Lang F; Risler T
Kidney Int; 2006 Dec; 70(12):2124-30. PubMed ID: 17063178
[TBL] [Abstract][Full Text] [Related]
7. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
Linnenweber S; Lonnemann G
Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
[TBL] [Abstract][Full Text] [Related]
8. Oesophageal defensin expression during Candida infection and reflux disease.
Kiehne K; Brunke G; Meyer D; Harder J; Herzig KH
Scand J Gastroenterol; 2005 May; 40(5):501-7. PubMed ID: 16036501
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
Kir HM; Eraldemir C; Dervisoglu E; Caglayan C; Kalender B
Clin Lab; 2012; 58(5-6):495-500. PubMed ID: 22783580
[TBL] [Abstract][Full Text] [Related]
10. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
12. α-Defensins and outcome in patients with chronic heart failure.
Christensen HM; Frystyk J; Faber J; Schou M; Flyvbjerg A; Hildebrandt P; Raymond I; Klausen TW; Kistorp C
Eur J Heart Fail; 2012 Apr; 14(4):387-94. PubMed ID: 22357441
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory, degenerative and vascular lesions in long-term dialysed patients.
Vrabie CD; Petrescu A; Waller M; Cojocaru M; Ciocâlteu A; Dina I
Rom J Intern Med; 2009; 47(2):149-59. PubMed ID: 20067165
[TBL] [Abstract][Full Text] [Related]
14. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
Ibrahim S
Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297
[TBL] [Abstract][Full Text] [Related]
15. High alpha-defensin levels in patients with systemic lupus erythematosus.
Sthoeger ZM; Bezalel S; Chapnik N; Asher I; Froy O
Immunology; 2009 May; 127(1):116-22. PubMed ID: 19191901
[TBL] [Abstract][Full Text] [Related]
16. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
[TBL] [Abstract][Full Text] [Related]
17. In vivo release of alpha-defensins in plasma, neutrophils and CD8 T-lymphocytes of patients with HIV infection.
D'Agostino C; Lichtner M; Mastroianni CM; Ceccarelli G; Iannetta M; Antonucci S; Vullo V; Massetti AP
Curr HIV Res; 2009 Nov; 7(6):650-5. PubMed ID: 19929802
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Stamatelou K; Triantafyllis G; Nicolaou C
Am J Nephrol; 2006; 26(1):91-6. PubMed ID: 16543712
[TBL] [Abstract][Full Text] [Related]
19. Altered serum levels of human neutrophil peptides (HNP) and human beta-defensin 2 (hBD2) in Wegener's granulomatosis.
Vordenbäumen S; Timm D; Bleck E; Richter J; Fischer-Betz R; Chehab G; Sander O; Schneider M
Rheumatol Int; 2011 Sep; 31(9):1251-4. PubMed ID: 21132301
[TBL] [Abstract][Full Text] [Related]
20. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
